LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Clinical trial NCT01345682 · COMPLETED

Trial details

NCT number: NCT01345682
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Head and Neck Neoplasms Carcinoma, Squamous Cell

Start date: 2012-01-05
Primary completion: 2014-03-15
Enrollment: 483

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.